This episode of Pharma Fundamentals explains the difference between a quality system for biologics compared with small-molecule drugs and the Parenteral Drug Association’s revision to Technical Report No. 56.
Amnon Eylath
Advertisement
Articles by Amnon Eylath
This episode of Pharma Fundamentals explains the difference between a quality system for biologics compared with small-molecule drugs and the Parenteral Drug Association’s revision to Technical Report No. 56.
IQ Consortium representatives explore industry approaches and practices for applying GMPs in early development.
IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What FDA's AI Warning Letter Tells Us About GMP Accountability
2
What Trutakna's FDA Approval Means for Specialty Biologics
3
Why Are Drugmakers Racing to Acquire ADC Payload Platforms?
4
Daraxonrasib Review Signals Shift in EU Drug Assessment Rules
5